Parisa Akbarpour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Parisa Akbarpour has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Azam Saei
Research Center for Trauma in Police Operations, Directorate of Health, Rescue & Treatment, Police Headquarter, Tehran, Iran
1 shared publication- Maryam Aligholizadeh
Department of Anesthesiology and Operating Room, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication - Mehrdad Mesbah Kiaei
Department of Anesthesiology and Pain Medicine, School of Medicine, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
1 shared publication - Shahnam Sedigh Maroufi
Department of Anesthesiology, School of Allied Medical Sciences Iran University of Medical Sciences Tehran Iran
1 shared publication - Siavash Sangi
Department of Anesthesiology and Operating Room, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 9 June 2024
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 9 (3)
The Effect of Ketamine Administration on the Incidence of Delirium After Coronary Artery Bypass Graft Surgery: A Scoping Review
Context: Delirium is a common complication observed in patients undergoing open-heart surgery, leading to adverse outcomes and increased healthcare costs. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist with analgesic and neuroprotective properties, has been reported to have potential protective effects against delirium. In this scoping review, we aim to explore the existing literature on the effect of ketamine administration in open-heart surgery on the incidence of delirium. Evidence Acquisition: In the latter part of 2023, a retrospective analysis was conducted to investigate the impact of administering ketamine on delirium occurrence following coronary artery bypass surgery. Researchers utilized Medical Subject Headings (MeSH) to identify key terms and searched various databases, including Scopus, Web of Science, PubMed, and Cochrane, as well as search engines like Google Scholar, alongside Iran SID and Iran ISC databases. Following the elimination of duplicates and irrelevant studies, the review encompassed six studies from Iran, Turkey, Canada, the United States, and Thailand. Results: The search strategy yielded 1100 articles, of which 100 were excluded due to duplicates. After excluding conference papers, systematic reviews, unrelated languages, unavailable full texts, and book chapters, 87 full-text studies were reviewed. Finally, 6 studies (5 studies in English and one study in Persian) met the inclusion criteria and were analyzed. Conclusions: Recent trials have shown that the effect of ketamine administration on the incidence of delirium after coronary artery bypass graft (CABG) surgery is equivocal. While some studies suggest that ketamine may serve as a promising solution for reducing the incidence of delirium, others suggest that it may lead to adverse experiences and raise concerns about its safety. Further research in this area is necessary to optimize postoperative recovery and minimize risks. Currently, physicians must carefully evaluate the potential benefits and side effects of ketamine for each patient and be aware of the latest evidence.
- 9 June 2024
- Published by Brieflands in Journal of Cellular & Molecular Anesthesia
- Vol. 9 (3)
Open AccessThe Effect of Ketamine Administration on the Incidence of Delirium After Coronary Artery Bypass Graft Surgery: A Scoping Review
Context: Delirium is a common complication observed in patients undergoing open-heart surgery, leading to adverse outcomes and increased healthcare costs. Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist with analgesic and neuroprotective properties, has been reported to have potential protective effects against delirium. In this scoping review, we aim to explore the existing literature on the effect of ketamine administration in open-heart surgery on the incidence of delirium. Evidence Acquisition: In the latter part of 2023, a retrospective analysis was conducted to investigate the impact of administering ketamine on delirium occurrence following coronary artery bypass surgery. Researchers utilized Medical Subject Headings (MeSH) to identify key terms and searched various databases, including Scopus, Web of Science, PubMed, and Cochrane, as well as search engines like Google Scholar, alongside Iran SID and Iran ISC databases. Following the elimination of duplicates and irrelevant studies, the review encompassed six studies from Iran, Turkey, Canada, the United States, and Thailand. Results: The search strategy yielded 1100 articles, of which 100 were excluded due to duplicates. After excluding conference papers, systematic reviews, unrelated languages, unavailable full texts, and book chapters, 87 full-text studies were reviewed. Finally, 6 studies (5 studies in English and one study in Persian) met the inclusion criteria and were analyzed. Conclusions: Recent trials have shown that the effect of ketamine administration on the incidence of delirium after coronary artery bypass graft (CABG) surgery is equivocal. While some studies suggest that ketamine may serve as a promising solution for reducing the incidence of delirium, others suggest that it may lead to adverse experiences and raise concerns about its safety. Further research in this area is necessary to optimize postoperative recovery and minimize risks. Currently, physicians must carefully evaluate the potential benefits and side effects of ketamine for each patient and be aware of the latest evidence.